Share：
Share this content in WeChat
X
[Chinese][PDF]75577
• Review •
Advance researches on MRI in evaluation of pathological differentiation for hepatocellular carcinoma
CHENG Dongliang  HUANG Weikang  WEN Ge  LIU Jianping  GAO Mingyong 

Cite this article as: Cheng DL, Huang WK, Wen G, et al. Advance researches on MRI in evaluation of pathological differentiation for hepatocellular carcinoma. Chin J Magn Reson Imaging, 2019, 10(9): 703-706. DOI:10.12015/issn.1674-8034.2019.09.014.


[Abstract] Pathological grade of hepatocellular carcinoma (HCC) is an independent predictor of tumor prognosis. Poorly differentiated HCC has a high recurrence rate and poor prognosis. So accurate grading of HCC is closely related to clinical decision and prognosis prediction. In this paper, MR in the evaluation of preoperative pathological grade of HCC was reviewed.
[Keywords] carcinoma, hepatocellular；pathology；magnetic resonance imaging

CHENG Dongliang Department of Radiology, the First People's Hospital of Foshan, Foshan 528000, China

HUANG Weikang Medical Imaging Center, Nanfang Hospital Zengcheng branch of Southern Medical University, Guangzhou 511300, China

WEN Ge Medical Imaging Center, Nanfang Hospital Zengcheng branch of Southern Medical University, Guangzhou 511300, China

LIU Jianping Department of Radiology, the First People's Hospital of Foshan, Foshan 528000, China

GAO Mingyong* Department of Radiology, the First People's Hospital of Foshan, Foshan 528000, China

*Corresponding to: Gao MY, E-mail: gmyong163@163.com

Conflicts of interest   None.

Received  2019-03-24
Accepted  2019-06-23
DOI: 10.12015/issn.1674-8034.2019.09.014
Cite this article as: Cheng DL, Huang WK, Wen G, et al. Advance researches on MRI in evaluation of pathological differentiation for hepatocellular carcinoma. Chin J Magn Reson Imaging, 2019, 10(9): 703-706. DOI:10.12015/issn.1674-8034.2019.09.014.

[1]
Fitzmorris P, Shoreibah M, Anand BS, et al. Management of hepatocellular carcinoma. J Cancer Res Clin Oncol, 2015, 141(5): 861-876.
[2]
Zimmerman M, Ghobrial RM, Hiatt J, et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg, 2008, 143(2): 182-188.
[3]
Chang WC, Chen RC, Chou CT, et al. Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images. Abdominal Imaging, 2014, 39(6): 1202-1212.
[4]
Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl, 2010, 11(9): 1086-1092.
[5]
胡国祥，郑丽民．肝细胞性肝癌CT表现与肿瘤病理分化相关性研究.中国中西医结合消化杂志, 2013,21(10): 537-538.
[6]
聂东雷．肝细胞癌的CT表现与CD34、GPC-3、HSP70表达、病理分级、患者预后的相关性研究．右江民族医学院, 2017.
[7]
Ojima H, Masugi Y, Tsujikawa H, et al. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions. Cancer Sci, 2016, 107(4): 543-550.
[8]
Nishie A, Yoshimitsu K, Okamoto D, et al. CT prediction of histological grade of hypervascular hepatocellular;carcinoma: utility of the portal phase. Jpn J Radiol, 2013, 31(2): 89-98.
[9]
Yang D, Li R, Zhang XH, et al. Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound: influence of the cellular differentiation, the tumor size and the underlying hepatic condition. Sci Rep, 2018, 8(1): 4713.
[10]
蓝艺婷. Gd-BOPTA增强MRI肝胆期联合DWI对肝细胞癌病理分级的预测研究．福建医科大学, 2017.
[11]
黄小芳．肝癌边缘假包膜与病理组织学分级相关性研究．广西医科大学, 2017.
[12]
Kim B, Lee JH, Kim JK, et al. The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: correlation with pathology and dynamic CT. Medicine (Baltimore), 2018, 97(25): e11142.
[13]
Ogihara Y, Kitazume Y, Iwasa Y, et al. Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study. Br J Radiol, 2018, 91(1084): 20170728.
[14]
Li X, Zhang K, Shi Y, et al. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade. J Magn Reson Imaging, 2016, 44(6): 1442-1447.
[15]
Nasu K, Kuroki YT. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol, 2009, 193(2): 438-444.
[16]
Hirano M, Satake H, Ishigaki S, et al. Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. AJR Am J Roentgenol, 2012, 198(3): 717.
[17]
贾文霄，陈敏．磁共振功能成像临床应用．北京：人民军医出版社, 2012: 35-68.
[18]
Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol, 2008, 18(3): 477-485.
[19]
Park IK, Yu JS, Cho ES, et al. Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging. PloS One, 2018, 13(5): e197070.
[20]
Woo S, Lee JM, Yoon JH, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology, 2014, 270(3): 758-767.
[21]
王倩倩，刘新疆. IVIM-DWI在肝脏局灶性病变中的应用进展．磁共振成像, 2018, 9(4): 312-315.
[22]
梁龙，陈文波，张斌，等．体素不相干运动扩散加权成像在鉴别头颈部鳞癌淋巴结转移中的应用．临床放射学杂志, 2016, 35(5): 696-701.
[23]
Zhu SC, Liu YH, Wei Y, et al. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging. World J Gastroenterol, 2018, 24(8): 929-940.
[24]
Luo M, Zhang L, Jiang XH, et al. Intravoxel incoherent motion diffusion-weighted imaging: evaluation of the differentiation of solid hepatic lesions. Transl Oncol, 2017, 10(5): 831-838.
[25]
Luo M, Zhang L, Jiang XH, et al. Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia. Diagn Interv Radiol, 2017, 23(4): 263-271.
[26]
Kim JH, Kim MJ, Park YN, et al. Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics. Clin Radiol, 2008, 63(11): 1195-1204.
[27]
Sutcliffe RP, Lewis D, Kane PA, et al. Manganese-enhanced MRI predicts the histological grade of hepatocellular carcinoma in potential surgical candidates. Clin Radiol, 2011, 66(3): 237-243.
[28]
Kim HY, Choi JY, Kim CW, et al. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class a cirrhosis. Liver Transpl, 2012, 18(7): 850-857.
[29]
Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology, 2014, 272(3): 635-654.
[30]
Channual S, Tan N, Siripongsakun S, et al. Gadoxetate disodium-enhanced MRI to differentiate dysplastic nodules and grade of hepatocellular carcinoma: correlation with histopathology. AJR Am J Roentgenol, 2015, 205(3): 546-553.
[31]
Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol, 2011, 21(10): 2056-2066.
[32]
赵云辉，许乙凯，高新疆．大鼠肝硬化肝癌SPIO增强MRI表现与Kupffer细胞的关系．放射学实践, 2009, 24(11): 1182-1186.
[33]
陈柱，肖恩华. SPIO纳米颗粒在肝癌磁共振早期诊断的基础研究进展．磁共振成像, 2015(4): 315-320.
[34]
Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology, 2000, 32(2): 205-212.

PREV The diffusion tensor imaging research of subcortical ischemic vascular disease
NEXT Progress of magnetic resonance elastography in nonalcoholic fatty liver disease
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn